Scynexis

#药闻简讯# $Scynexis(SCYX)$ SCY-247 获得 FDA 传染病合格产品 (QIDP) 和快速通道资格认定

$Scynexis(SCYX)$ 抗菌药物。
SCYX Receives FDA Qualified Infectious Disease Product (QIDP) and Fast Track Designations for SCY-247。小众但刚需

$Scynexis(SCYX)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001178253-26-000004  Size: 4 KB 网页链接

$Scynexis(SCYX)$ 8-K Current report, items 1.01, 3.02, 7.01, 8.01, and 9.01 Accession Number: 0001193125-26-133259  Act: 34  Size: 828 KB 网页链接

$Scynexis(SCYX)$ SCHEDULE 13G/A [Amend] Statement of Beneficial Ownership by Certain Investors Accession Number: 0000919574-26-001061  Act: 34  Size: 12 KB 网页链接

$Scynexis(SCYX)$ SCHEDULE 13G/A [Amend] Statement of Beneficial Ownership by Certain Investors Accession Number: 0000919574-26-001062  Act: 34  Size: 31 KB 网页链接

$Scynexis(SCYX)$ 10-K Annual report [Section 13 and 15(d), not S-K Item 405] Accession Number: 0001178253-26-000007  Act: 34  Size: 12 MB 网页链接

$Scynexis(SCYX)$ 8-K Current report, items 1.01, 2.01, 7.01, and 9.01 Accession Number: 0001193125-26-133250  Act: 34  Size: 191 KB 网页链接

$Scynexis(SCYX)$ SCHEDULE 13G/A [Amend] Statement of Beneficial Ownership by Certain Investors Accession Number: 0001623632-26-000036  Act: 34  Size: 46 KB 网页链接

$Scynexis(SCYX)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001178253-26-000003  Size: 4 KB 网页链接

$Scynexis(SCYX)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001193125-26-033583  Size: 4 KB 网页链接

$Scynexis(SCYX)$ 8-K Current report, items 7.01 and 9.01 Accession Number: 0001193125-26-134476  Act: 34  Size: 8 MB 网页链接

$Scynexis(SCYX)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001644071-26-000002  Size: 8 KB 网页链接